Atlas Trials

A Phase I Clinical Study of IX001 TCR-T Injection in the Treatment of Advanced Pancreatic Cancer Patients With KRAS G12V Mutation

Clinical trial NCT06898385 · RECRUITING

Trial details

NCT number
NCT06898385
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2025-03-27
Primary completion
2027-03-27
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.